SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-407860
Filing Date
2014-11-12
Accepted
2014-11-12 07:51:20
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d796294d10q.htm 10-Q 680222
2 EX-31.1 d796294dex311.htm EX-31.1 7072
3 EX-31.2 d796294dex312.htm EX-31.2 7043
4 EX-32.1 d796294dex321.htm EX-32.1 3963
5 EX-32.2 d796294dex322.htm EX-32.2 3920
  Complete submission text file 0001193125-14-407860.txt   3965152

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ocul-20140930.xml EX-101.INS 421209
7 XBRL TAXONOMY EXTENSION SCHEMA ocul-20140930.xsd EX-101.SCH 40336
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocul-20140930_cal.xml EX-101.CAL 53456
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocul-20140930_def.xml EX-101.DEF 134052
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20140930_lab.xml EX-101.LAB 345812
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20140930_pre.xml EX-101.PRE 237839
Mailing Address 36 CROSBY DRIVE SUITE 101 BEDFORD MA 01730
Business Address 36 CROSBY DRIVE SUITE 101 BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 141211119
SIC: 2834 Pharmaceutical Preparations